These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124 [TBL] [Abstract][Full Text] [Related]
4. The COVID-19 pandemic. Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276 [TBL] [Abstract][Full Text] [Related]
5. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges]. Wang J; Zou W; Liu J Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563 [TBL] [Abstract][Full Text] [Related]
6. How to deal and learn from the threat of COVID-19 in paediatric dentistry. Acharya S; Singh B; Godhi B; Godhi B; Pandey S Eur J Paediatr Dent; 2020 Sep; 21(3):173-175. PubMed ID: 32893646 [TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913 [TBL] [Abstract][Full Text] [Related]
8. COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures. Mackenzie JS; Smith DW Asia Pac J Public Health; 2020 May; 32(4):145-153. PubMed ID: 32475144 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell research progress for the treatment of COVID-19. Yao D; Ye H; Huo Z; Wu L; Wei S J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Zayed M; Iohara K Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. Wei J; Zhao J; Han M; Meng F; Zhou J J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811 [TBL] [Abstract][Full Text] [Related]
13. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review]. Shi X; Yu L; Ding C Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564 [TBL] [Abstract][Full Text] [Related]
14. [The first wave of COVID-19 in Intensive care]. Marchetta S; Lambermont B; Massion P; Rousseau AF; Layios N; Robinet S; Canivet JL; Kisoka G; Ledoux D; Morimont P; Piret S; Wiesen P; Misset B Rev Med Liege; 2020 Sup; 75(S1):18-28. PubMed ID: 33211418 [TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China. Cao Y; Cai K; Xiong L Acta Virol; 2020; 64(2):245-250. PubMed ID: 32551792 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide. Liu NN; Tan JC; Li J; Li S; Cai Y; Wang H Curr Cancer Drug Targets; 2020; 20(6):410-416. PubMed ID: 32286947 [TBL] [Abstract][Full Text] [Related]
17. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449 [TBL] [Abstract][Full Text] [Related]
18. Response to Covid-19: An ethical imperative to build a resilient health system in India. Gopichandran V; Subramaniam S Indian J Med Ethics; 2020; V(2):1-4. PubMed ID: 32393458 [TBL] [Abstract][Full Text] [Related]
19. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment. Wang XY Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992 [TBL] [Abstract][Full Text] [Related]
20. Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020. New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team MMWR Morb Mortal Wkly Rep; 2020 May; 69(19):603-605. PubMed ID: 32407306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]